Diversified Healthcare Trust (NASDAQ:DHC) Stock Has Consensus Target Price of $9.83 According to Analysts

Key Points

• Analysts have a Moderate Buy consensus on Diversified Healthcare Trust, with six firms reporting an average 12-month price target of $9.83 versus the stock’s $7.86 opening price.
• DHC’s latest quarter fell slightly short of expectations, reporting a loss of $0.16 per share versus the $0.15 consensus estimate and revenue of $365.39 million versus $370.75 million expected.
• The REIT declared a quarterly dividend of $0.01 per share, equivalent to $0.04 annually and a 0.5% yield; institutional investors own approximately 75.98% of the stock.

Shares of Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) have received an average recommendation of "Moderate Buy" from the six research firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $9.83.

Several analysts have recently issued reports on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Diversified Healthcare Trust in a research report on Thursday, October 15th. Wall Street Zen raised Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research note on Saturday, August 8th.

Diversified Healthcare Trust Stock Down 0.1%

NASDAQ DHC opened at $7.86 on Friday. The stock has a market capitalization of $1.90 billion, a PE ratio of -7.08 and a beta of 2.29. Diversified Healthcare Trust has a 1 year low of $3.92 and a 1 year high of $9.66. The business's 50-day moving average is $7.79 and its 200 day moving average is $8.26. The company has a debt-to-equity ratio of 1.52, a current ratio of 4.66 and a quick ratio of 4.67.

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.01). Diversified Healthcare Trust had a negative return on equity of 16.22% and a negative net margin of 17.73%. The firm had revenue of $365.39 million during the quarter, compared to the consensus estimate of $370.75 million. Sell-side analysts forecast that Diversified Healthcare Trust will post 0.60 earnings per share for the current year.

Diversified Healthcare Trust Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 12th. Stockholders of record on Monday, October 19th will be paid a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, October 19th. This represents a $0.04 annualized dividend and a dividend yield of 0.5%. Diversified Healthcare Trust's payout ratio is currently -3.60%.

Hedge Funds Weigh In On Diversified Healthcare Trust

Several large investors have recently added to or reduced their stakes in DHC. Carronade Capital Management LP grew its stake in shares of Diversified Healthcare Trust by 10.6% in the first quarter. Carronade Capital Management LP now owns 5,268,435 shares of the real estate investment trust's stock worth $34,982,000 after purchasing an additional 504,898 shares in the last quarter. Bank of America Corp DE boosted its position in Diversified Healthcare Trust by 90.4% during the first quarter. Bank of America Corp DE now owns 2,682,265 shares of the real estate investment trust's stock valued at $17,810,000 after purchasing an additional 1,273,681 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Diversified Healthcare Trust by 6.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,399,804 shares of the real estate investment trust's stock valued at $15,935,000 after purchasing an additional 138,708 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in Diversified Healthcare Trust by 125.1% in the 1st quarter. Bank of New York Mellon Corp now owns 2,390,413 shares of the real estate investment trust's stock worth $15,872,000 after acquiring an additional 1,328,648 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Diversified Healthcare Trust by 30.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,354,824 shares of the real estate investment trust's stock valued at $15,636,000 after buying an additional 552,794 shares during the last quarter. 75.98% of the stock is currently owned by institutional investors.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust NASDAQ: DHC is a real estate investment trust that owns and manages healthcare-related properties in the United States. Its portfolio includes medical office buildings, life science and research facilities, senior living communities, and wellness-oriented properties.

The trust leases its properties to healthcare providers, research organizations, senior living operators, and other related businesses. Its medical office and life science properties support outpatient care, medical research, and healthcare innovation, while its senior living portfolio serves older adults through independent living, assisted living, and related care services.

DHC was formerly known as Senior Housing Properties Trust and adopted its current name in 2020 to reflect its broader healthcare real estate strategy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.